| Effect of intermediate-dose vs standard-dose prophylactic anticoagulation on thrombotic events, extracorporeal membrane oxygenation treatment, or mortality among patients with … S Mazloomzadeh, S Khaleghparast, B Ghadrdoost, M Mousavizadeh, ... Jama 325 (16), 1620-1630, 2021 | 726 | 2021 |
| 2017 ACC expert consensus decision pathway on management of bleeding in patients on oral anticoagulants: a report of the American College of Cardiology Task Force on Expert … GF Tomaselli, KW Mahaffey, A Cuker, PP Dobesh, JU Doherty, ... Journal of the American College of Cardiology 70 (24), 3042-3067, 2017 | 699 | 2017 |
| Guidance for the practical management of the heparin anticoagulants in the treatment of venous thromboembolism MA Smythe, J Priziola, PP Dobesh, D Wirth, A Cuker, AK Wittkowsky Journal of thrombosis and thrombolysis 41, 165-186, 2016 | 278 | 2016 |
| American College of Clinical Pharmacy's vision of the future: postgraduate pharmacy residency training as a prerequisite for direct patient care practice JE Murphy, JM Nappi, JA Bosso, JJ Saseen, BA Hemstreet, MA Halloran, ... Pharmacotherapy 26 (5), 722-733, 2006 | 276 | 2006 |
| Ticagrelor: pharmacokinetics, pharmacodynamics, clinical efficacy, and safety PP Dobesh, JH Oestreich Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 34 (10 …, 2014 | 248 | 2014 |
| Economic burden of venous thromboembolism in hospitalized patients PP Dobesh Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 29 (8 …, 2009 | 193 | 2009 |
| Reduction in mortality associated with statin therapy in patients with severe sepsis PP Dobesh, DG Klepser, TR McGuire, CW Morgan, KM Olsen Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 29 (6 …, 2009 | 110 | 2009 |
| Pharmacokinetics and pharmacodynamics of prasugrel, a thienopyridine P2Y12 inhibitor PP Dobesh Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 29 (9 …, 2009 | 106 | 2009 |
| Adherence and dosing frequency of common medications for cardiovascular patients. JP Bae, PP Dobesh, DG Klepser, JD Anderson, AJ Zagar, PL McCollam, ... The American journal of managed care 18 (3), 139-146, 2012 | 105 | 2012 |
| Coagulopathy, venous thromboembolism, and anticoagulation in patients with COVID‐19 PP Dobesh, TC Trujillo Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 40 (11 …, 2020 | 100 | 2020 |
| Are hospitals delivering appropriate VTE prevention? The venous thromboembolism study to assess the rate of thromboprophylaxis (VTE start) A Amin, AC Spyropoulos, P Dobesh, A Shorr, M Hussein, E Mozaffari, ... Journal of thrombosis and thrombolysis 29, 326-339, 2010 | 93 | 2010 |
| Intermediate-dose versus standard-dose prophylactic anticoagulation in patients with COVID-19 admitted to the intensive care unit: 90-day results from the INSPIRATION … B Bikdeli, AH Talasaz, F Rashidi, H Bakhshandeh, F Rafiee, P Rezaeifar, ... Thrombosis and haemostasis 122 (01), 131-141, 2022 | 85 | 2022 |
| Effect of a clinical pharmacy education program on improvement in the quantity and quality of venous thromboembolism prophylaxis for medically ill patients PP Dobesh, ZA Stacy Journal of managed care pharmacy 11 (9), 755-762, 2005 | 80 | 2005 |
| Drug‐Eluting Stents: A Mechanical and Pharmacologic Approach to Coronary Artery Disease PP Dobesh, ZA Stacy, AJ Ansara, JM Enders Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 24 (11 …, 2004 | 60 | 2004 |
| Management of periprocedural anticoagulation: a survey of contemporary practice GC Flaker, P Theriot, LG Binder, PP Dobesh, A Cuker, JU Doherty Journal of the American College of Cardiology 68 (2), 217-226, 2016 | 58 | 2016 |
| Clinical use of rivaroxaban: pharmacokinetic and pharmacodynamic rationale for dosing regimens in different indications T Trujillo, PP Dobesh Drugs 74, 1587-1603, 2014 | 54 | 2014 |
| Renal function considerations for stroke prevention in atrial fibrillation J Fanikos, AE Burnett, CE Mahan, PP Dobesh The American journal of medicine 130 (9), 1015-1023, 2017 | 52 | 2017 |
| Direct oral anticoagulants for the prevention of stroke in patients with nonvalvular atrial fibrillation: understanding differences and similarities PP Dobesh, J Fanikos Drugs 75, 1627-1644, 2015 | 48 | 2015 |
| Real-world management of oral factor Xa inhibitor-related bleeds with reversal or replacement agents including andexanet alfa and four-factor prothrombin complex concentrate: a … CI Coleman, PP Dobesh, S Danese, J Ulloa, B Lovelace Future Cardiology 17 (1), 127-135, 2021 | 46 | 2021 |
| Statins role in the prevention and treatment of sepsis PP Dobesh, KM Olsen Pharmacological research 88, 31-40, 2014 | 43 | 2014 |
